Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
ID: 351106Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $450K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/351106

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-067.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for R34 planning grants aimed at developing prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD). This initiative seeks to support research focused on reducing prenatal alcohol exposure and enhancing interventions throughout an individual's lifespan, ultimately leading to pilot data for larger-scale studies. The program encourages applications from a diverse range of entities, including higher education institutions and community organizations, with a funding ceiling of $450,000 available for projects lasting up to three years. Interested applicants should submit their proposals by January 7, 2027, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-067.html for further details.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-067-Full-Announcement.html
    PAR-24-067.html
    The Department of Health and Human Services, through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has issued a Notice of Funding Opportunity (NOFO) for R34 planning grants aimed at developing prevention and intervention strategies for Fetal Alcohol Spectrum Disorders (FASD). This initiative focuses on reducing prenatal alcohol exposure and enhancing interventions throughout an individual’s lifespan. Research supported by this grant should lead to pilot data for future large-scale prevention or intervention studies. Applications are encouraged from diverse entities, including higher education institutions and nonprofits, with a budget limit of $450,000 for a three-year project period. The submission dates for applications are set with specific deadlines, along with instructions for a Data Management and Sharing Plan that aligns with NIH requirements. Key research areas include innovative strategies to help women abstain from alcohol during pregnancy, culturally sensitive intervention designs, and improving care for individuals with FASD. Notably, applications related to multiple substance exposures are eligible, but the primary focus remains on prenatal alcohol use. This funding opportunity reflects a critical effort to advance clinical and social understanding of FASD and create effective interventions for affected populations.
    Similar Opportunities
    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)" aimed at supporting research on strategies to prevent and intervene in fetal alcohol spectrum disorders (FASD). The initiative seeks proposals that focus on reducing prenatal alcohol exposure and improving interventions for individuals affected by FASD, utilizing the Exploratory/Developmental Phased Award (R61/R33) mechanism, which allows for pilot studies in the initial phase and potential expansion in the subsequent phase based on milestone achievements. This funding is crucial for addressing significant public health challenges related to prenatal alcohol exposure, with a total award ceiling of $350,000 and no cost-sharing requirements. Interested applicants must submit their proposals by January 16, 2024, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-068.html.
    Alcohol Health Services Research (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)" (PAR-23-252). This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on improving access to treatment, reducing stigma, examining cost structures, and implementing evidence-based approaches, particularly for health disparity populations. The total project budget is capped at $450,000 over a three-year period, and eligible applicants include higher education institutions, nonprofits, and government agencies, with a specific emphasis on those serving underrepresented communities. Interested parties should submit their applications electronically by October 16, 2023, with funding available until September 8, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    HIV Prevention and Alcohol (R34 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R34 Clinical Trials Optional)" aimed at expanding the HIV/AIDS prevention toolkit among populations impacted by alcohol use. This grant seeks to support research that integrates effective prevention and treatment interventions while addressing the behavioral and biological risks associated with alcohol consumption, particularly among high-risk groups. The initiative is crucial for informing the design of future clinical trials focused on HIV prevention, with an anticipated funding amount of approximately $1.5 million for 2-4 awards. Interested applicants, including higher education institutions and community organizations, must submit their proposals by September 7, 2025, and can find additional information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials," aimed at encouraging pilot research to develop and test interventions that prevent or delay substance use. The initiative focuses on the creation and pilot testing of new or adapted strategies to curb substance misuse, particularly among underserved populations, while also addressing related negative outcomes such as impaired driving and transmission of infectious diseases. Eligible applicants include a wide range of institutions, such as academic, nonprofit, and government organizations, with funding available up to $450,000 over three years. Interested parties should note that applications are due starting January 16, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    Specialized Alcohol Research Centers (P50 Clinical trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of Specialized Alcohol Research Centers (P50), aimed at advancing interdisciplinary research on Alcohol Use Disorder (AUD) and related issues. This initiative seeks to foster collaborative research that examines the etiology, treatment, and prevention of AUD, particularly focusing on health disparities among various racial and ethnic populations. The total funding commitment for this opportunity is up to $7 million, with applications due by November 15, 2024, and a requirement for a Plan for Enhancing Diverse Perspectives (PEDP) to be included in submissions. Interested applicants can find more information and submit their proposals electronically through Grants.gov, with inquiries directed to grantsinfo@nih.gov.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the R34 Clinical Trial mechanism focused on Alcohol Treatment, Pharmacotherapy, and Recovery Research. This initiative aims to enhance understanding and treatment strategies for Alcohol Use Disorder (AUD) through clinical trials, with a particular emphasis on increasing access to treatment, improving treatment appeal, examining cost structures, and addressing health disparities among affected populations. The program is open to a diverse range of applicants, including educational institutions, nonprofits, and government agencies, with funding limits set at $450,000 over a maximum three-year project period. Interested parties must submit their applications by October 16, 2023, and can direct inquiries to grantsinfo@nih.gov for further information.
    HIV Prevention and Alcohol (R01 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R01 Clinical Trials Optional)" aimed at expanding HIV prevention strategies among populations affected by alcohol use. This initiative encourages research projects that explore the relationship between alcohol consumption and HIV risk behaviors, focusing on areas such as Pre-exposure Prophylaxis (PrEP) utilization, Treatment as Prevention (TasP), and the integration of preventive intervention strategies. The program is particularly significant for addressing health disparities among high-risk groups, including men who have sex with men (MSM) and women with high-risk partners. The NIH anticipates funding between $2 million for 2 to 4 awards, with a project period of up to five years. Interested applicants can submit their proposals through the NIH ASSIST system or Grants.gov, and should direct inquiries to grantsinfo@nih.gov. The application deadline is May 7, 2026.
    Alcohol Health Services Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the Alcohol Health Services Research (R01 Clinical Trial Optional) grant. This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing the appeal of treatment, examining cost structures and insurance systems, studying the dissemination and implementation of evidence-based approaches, and reducing health disparities among affected populations. The grant allows for a maximum budget of $500,000 and a project period of up to five years, with applications due by September 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)." This initiative aims to support pilot and preliminary research that prepares for larger-scale trials focused on improving access to and the effectiveness of treatment services for substance use disorders. The funding is intended to facilitate the testing of various intervention approaches and methodologies, ultimately contributing to the development of effective treatment strategies that address health disparities among vulnerable populations. Applicants may receive up to $450,000 over a three-year period, with proposals due by 5:00 PM local time on January 7, 2025. For further information, interested parties can contact the NIH OER Webmaster at grantsinfo@nih.gov or visit the official announcement at http://grants.nih.gov/grants/guide/pa-files/PA-21-180.html.
    Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) aimed at supporting the development of medications for Alcohol Use Disorder (AUD) and Alcohol-Associated Organ Damage (AAOD) through Small Business Innovation Research (SBIR) applications. Eligible applicants, specifically U.S.-based small businesses, are required to propose therapeutic agents that have a solid foundation of background data, ready for transition to preclinical and clinical development, with a focus on advancing these candidates towards FDA approval. This initiative is critical given the limited FDA-approved treatments available for AUD and AAOD, and it emphasizes the importance of rigorous scientific and regulatory standards in drug development. Funding amounts include up to $1 million for Phase I and $1.5 million for Phase II, with project durations of up to two years and three years, respectively. Interested parties can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with the application deadline set for December 4, 2024.